MalariaGEN

Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

Issaka Sagara, Abdoul Habib Béavogui, Issaka Zongo et al. · The Lancet · 2018 · 142 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

Ethnobotanical survey and in vitro antiplasmodial activity of plants used in traditional medicine in Burkina Faso

S. Sanon, Évelyne Ollivier, Nadine Azas et al. · Journal of Ethnopharmacology · 2003 · 132 citations

Life Sciences, Botany, Plant Sciences +14

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018

Adama Gansané, Leah F. Moriarty, Didier Ménard et al. · Malaria Journal · 2021 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial

Issaka Sagara, Abdoul Habib Béavogui, Issaka Zongo et al. · The Lancet Infectious Diseases · 2015 · 87 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Antiplasmodial activity of alkaloid extracts from Pavetta crassipes (K. Schum) and Acanthospermum hispidum (DC), two plants used in traditional medicine in Burkina Faso

S. Sanon, Nadine Azas, M. Gasquet et al. · Parasitology Research · 2003 · 61 citations

Life Sciences, Botany, Pharmacology +13